Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Canadian journal of ophthalmology 2015-12, Vol.50 (6), p.409-412
Hauptverfasser:	Mireskandari, Kamiar, FRCOphth, PhD, Collins, Megan E, MD, Tehrani, Nasrin, FRCSEd (Ophth), FRCSC
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors - adverse effects Angiogenesis Inhibitors - therapeutic use Bevacizumab - adverse effects Bevacizumab - therapeutic use Humans Infant Infant, Newborn Informed Consent Internal Medicine Intravitreal Injections Ophthalmology Practice Guidelines as Topic Retinopathy of Prematurity - drug therapy Risk Factors Vascular Endothelial Growth Factor A - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!